Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Cecelia Boardman MD
To determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of adjuvant carboplatin and paclitaxel chemotherapy following concurrent weekly cisplatin chemotherapy and extended field radiation in women with newly diagnosed Stage IB-IVA cervical cancer, with positive para-aortic nodes.
To determine the feasibility of the treatment regimen over the four cycles of adjuvant chemotherapy once the MTD in estimated.
To assess the toxicities of the treatment regimen the NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0.
Women with newly diagnosed Stage IB-IVA cervical cancer, with positive para-aortic nodes.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.